- Home
- CRT vs FORA Comparison
CRT vs FORA Comparison
Compare CRT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- FORA
- Stock Information
- Founded
- CRT 1991
- FORA 2014
- Country
- CRT United States
- FORA United States
- Employees
- CRT N/A
- FORA N/A
- Industry
- CRT Oil & Gas Production
- FORA Computer Software: Prepackaged Software
- Sector
- CRT Energy
- FORA Technology
- Exchange
- CRT Nasdaq
- FORA Nasdaq
- Market Cap
- CRT 64.0M
- FORA 62.7M
- IPO Year
- CRT 1992
- FORA N/A
- Fundamental
- Price
- CRT $10.32
- FORA $1.96
- Analyst Decision
- CRT
- FORA Strong Buy
- Analyst Count
- CRT 0
- FORA 1
- Target Price
- CRT N/A
- FORA $5.00
- AVG Volume (30 Days)
- CRT 39.7K
- FORA 30.3K
- Earning Date
- CRT 01-01-0001
- FORA 05-13-2025
- Dividend Yield
- CRT 8.33%
- FORA N/A
- EPS Growth
- CRT N/A
- FORA N/A
- EPS
- CRT 0.95
- FORA N/A
- Revenue
- CRT $6,623,430.00
- FORA $20,153,263.00
- Revenue This Year
- CRT N/A
- FORA $13.31
- Revenue Next Year
- CRT N/A
- FORA N/A
- P/E Ratio
- CRT $10.91
- FORA N/A
- Revenue Growth
- CRT N/A
- FORA N/A
- 52 Week Low
- CRT $8.88
- FORA $1.85
- 52 Week High
- CRT $14.98
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- CRT 43.03
- FORA 46.06
- Support Level
- CRT $9.20
- FORA $1.90
- Resistance Level
- CRT $11.46
- FORA $2.08
- Average True Range (ATR)
- CRT 0.90
- FORA 0.12
- MACD
- CRT -0.09
- FORA 0.02
- Stochastic Oscillator
- CRT 27.25
- FORA 41.02
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.